Qualcomm-Arm Contract Clash Returns: Billions at Stake

Key Moments

Qualcomm claims Arm failed to provide agreed chip testing tools and seeks to halt royalty payments for up to five years
Arm denies breaching the contract and says any alleged impact on Qualcomm’s chip talks with Meta Platforms was speculative
Judge Maryellen Noreika is considering whether to strike a key contract term that underpins Qualcomm’s bid for potentially massive damages

Renewed Court Battle in Delaware

WILMINGTON, Delaware, Oct 5 (Reuters) – Qualcomm and Arm Holdings are set to face each other in a US federal courtroom on Monday, reigniting a long-running dispute between the two chip industry heavyweights. Qualcomm alleges that Arm failed to deliver chip testing tools it was contractually obligated to provide, and is pressing the court for substantial financial relief.

The case is being heard in Delaware federal court, where Qualcomm – identified as one of Arm’s largest customers – is pushing to stop paying royalties to Arm for as long as five years. According to Qualcomm, those royalty payments could be worth billions of dollars.

Disputed Royalties and Contract Terms

At the center of the lawsuit is a contested provision in the companies’ contract. Qualcomm argues that Arm’s alleged failure to supply required chip testing tools justifies its effort to halt royalty payments over a multi-year period.

Judge Maryellen Noreika is currently evaluating whether that particular contract term is enforceable. If she removes it from the case, Qualcomm’s potential recovery could be substantially reduced, limiting the company to a much smaller set of damages.

Alleged Leak and Meta Deal Impact

Qualcomm further contends that Arm disclosed to the media its 2024 warning that it could terminate a critical license agreement with Qualcomm. According to Qualcomm, that disclosure interfered with ongoing discussions for a chip agreement between Qualcomm and Meta Platforms.

Arm has rejected Qualcomm’s accusations, stating that it did not violate the contract and that Qualcomm’s assertions about lost chip business are speculative. Arm also argues that Qualcomm should not be able to pursue damages tied to the alleged leak of Arm’s termination letter, asserting that Qualcomm itself disclosed non-public information about antitrust investigations into Arm to the media.

Key Legal Positions

Party	Primary Claim	Response / Counter
Qualcomm	Arm withheld contractually required chip testing tools and leaked a 2024 termination threat that harmed Qualcomm’s chip deal discussions with Meta Platforms.	Seeks to stop paying Arm royalties – potentially in the billions of dollars – for up to five years.
Arm	Denies breaching the contract and says alleged harm to Qualcomm’s chip negotiations is speculative.	Argues Qualcomm cannot recover for the alleged leak because Qualcomm disclosed non-public antitrust probe details about Arm to the media.

Jury Trial and Parallel Bench Proceedings

The dispute will be heard in a five-day jury trial, adding another chapter to what has been a highly contentious relationship between the two firms. The litigation traces back to 2022, when Arm sued Qualcomm claiming contract breaches. Qualcomm secured a key win in 2024, but the broader commercial relationship remains under legal scrutiny.

In a separate but related bench trial, also before Judge Noreika, the court will consider whether Arm has engaged in good faith negotiations with Qualcomm over licensing for the next generation of Arm’s chip technology. The companies’ existing agreement extends through 2033, making the outcome of these negotiations critical for their long-term collaboration.

Evolving Competitive Dynamics

Qualcomm has traditionally been a leading supplier of chips for Android smartphones and has moved into other segments such as data center chips. For decades, Arm has provided foundational chip design technology to Qualcomm and other chip designers, including Nvidia.

More recently, Arm has begun offering its own chips, placing it in direct competition with some of its established customers. This shift has added further tension to a relationship already strained by contractual and licensing disputes.